The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients

Background: Inconclusive bone scans are a challenge but there is no consensus about follow-up imaging. We evaluated the use of <sup>68</sup>gallium-labelled prostate-specific membrane antigen (<sup>68</sup>Ga-PSMA) PET/CT if <sup>18</sup>F-sodium fluoride (<sup...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Claus Madsen, Peter Østergren, Christian Haarmark
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-05-01
Series:Diagnostics
Assuntos:
PSMA PET/CT
NaF PET/CT
prostate cancer
bone metastases
Acceso en liña:https://www.mdpi.com/2075-4418/10/6/352
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares